Why Nucor’s Stock Dip Could Be a Golden Opportunity in Disguise
Nucor (NYSE: NUE) isn’t just another steelmaker churning out metal for skyscrapers and rebar. It’s a powerhouse that has weathered economic storms, steel cycles, and shifting energy costs, all while steadily raising its dividend for over the past half century.
Yet, despite that remarkable consistency, investors seems to be snoozing on Nucor right now so is it time to buy?
» Read more about: Why Nucor’s Stock Dip Could Be a Golden Opportunity in Disguise »
Read More
Why Billionaire with PERFECT Record Bought This Stock?
Buffett may be richer than Stan Druckenmiller, but he can’t claim a perfect trading record without a single down year as the founder of Duquense Family Office can.
And in its latest filings, Duquense has snapped up a company that is so far under most radars, it likely is invisible. That company is GE Vernova (GEV) and it’s got some bullish catalysts that may well be worth spending a little time on to see if they compel you to buy as they did Stan.
» Read more about: Why Billionaire with PERFECT Record Bought This Stock? »
Read More
You’re About To Spit Out Your Coffee
While the market has generally been trending higher this year with various bumps in the road, Starbucks has had an altogether different journey and remained largely flat over the past 12 months. Worse still, until its recent CEO switchover, it had been decidedly under water.
The fundamentals have been fairly underwhelming for some time as earnings reports have revealed.
» Read more about: You’re About To Spit Out Your Coffee »
Read More
Can eBay Skyrocket by 33%?
As ever more customers are turning to online retail, global e-commerce revenue is projected to grow at an annual growth rate of 9.5%, reaching an astonishing volume of $6.48 trillion by 2029.
Among the most promising e-commerce firms now is arguably one of the original pioneers in the space, eBay. Here’s why.
» Read more about: Can eBay Skyrocket by 33%? »
Read More
4% Dividend + 12x Earnings = Blockbuster in the Making
Merck has long been a pillar of stability in the pharmaceutical world, thanks in large part to the staggering success of its cancer drug Keytruda. But behind that success lies a quietly growing concern of what happens when the patents expire?
In a move that could reshape its future, Merck just announced a $10 billion acquisition of Verona Pharma.
» Read more about: 4% Dividend + 12x Earnings = Blockbuster in the Making »
Read MoreThe Burst
Will Amazon Stock Make You a Millionaire In 10 Years?
Amazon isn’t just a retailer. It’s an ecosystem and it’s hard to find another company with the same mix of scale, efficiency, and stickiness across multiple trillion-dollar industries.
Start with e-commerce. Amazon’s scale gives it a cost advantage that smaller rivals simply can’t touch. After pouring tens of billions into logistics, robotics, and AI-driven warehouse optimization,
» Read more about: Will Amazon Stock Make You a Millionaire In 10 Years? »
Read MoreThe Spotlight
1 Stock Buffett Likes More Than Apple
Stocks have pulled back in the past month, as interest rates and inflation continue to dog the market. The AI excitement that gripped investors earlier in the year has abated somewhat, leading to recent pullbacks in stocks like Nvidia and Microsoft.
Apple has struggled to make an impact with investors because the company has lagged behind its competitors in launching AI-powered products.
» Read more about: 1 Stock Buffett Likes More Than Apple »
Read More